|Day Low/High||202.69 / 205.33|
|52 Wk Low/High||150.37 / 234.26|
A pair of earnings report this week will shed light on the future direction of two fast-growing companies in very different fields.
Oh, by the way, Constellation, for those who've forgotten, holds a 38% stake in Canopy Growth.
There is certainly too much to ignore about STZ for the majority of analysts.
The consumer is alive, well, and might benefit from a thaw with China and easy to get jobs. So would Boeing and Caterpillar.
What I do know is that TSLA now faces a tumultuous uphill battle in order to meet its full year guidance.
I am upping my Apple price target.
What to look for when Dave & Buster's and Constellation Brands report results.
I've noted a few names from the comments that may be involved in the CBD-infused beverage market in the form of New Age Beverage Corp. and Constellation Brands . While I'm a big supporter in the potential of CBD and cannabis, I have my reservations ...
Not to be outcome by a unicorn company, the unicorn sector of the markets, cannabis, is unleashing a blitzkrieg of news this morning. On the acquisition side, Cresco Labs is buying Origin House (CannaRoyalty) this morning for a small premium. It app...
Investors can gain exposure to the high-flying cannabis industry without taking on undue risks.
The move was helped by the TLRY's deals with AB InBev for beverages and Novartis for medical applications.
Assessing Aurora and its peers, strictly on the numbers.
In this day and age, companies must be 'disruptors' or get left in the dust.
I know that Nelson is fascinated by the medicinal properties chiefly as a replacement for opioids, the scourge of this country.
Aurora's prominent partner could be cannabis' key to breaking into consumer segments.
In its first report on cannabis companies, Melius says prices are high.
And why I won't recommend any other stocks in these markets, right now.
If you are looking to invest in the fast-growing pot sector, this Canadian cannabis startup has been in early on the action.
Right now they are speculative growth stocks through and through.
Eight of these 11 trade ideas are in the green, with a few big winners.
While consolidation may be key to the cannabis market in 2019, this IPO is worthy of a deeper dive.
CBD could make coffee an around the clock craze.
Canopy Growth's smoking engine won't necessarily ensure smooth sailing for Constellation.
Analysts have noted that the weed leader's momentum is set to burn higher moving forward.
I'm strategizing a risk reversal here using a put sale to fund a long-side play.